Literature DB >> 20386259

Dynamic deconstructive psychotherapy versus optimized community care for borderline personality disorder co-occurring with alcohol use disorders: a 30-month follow-up.

Robert J Gregory1, Evan DeLucia-Deranja, Jacqueline A Mogle.   

Abstract

Patients having co-occurring borderline personality disorder and alcohol use disorders represent a common, but particularly severe and refractory subgroup. An individual, time-limited treatment, dynamic deconstructive psychotherapy (DDP), has been shown to be effective for this subgroup, but long-term outcomes are not known. Participants were recruited from a sample of 30 patients enrolled in a 12-month randomized controlled trial of DDP versus optimized community care (OCC). Outcomes were assessed after an additional 18 months of naturalistic follow-up. DDP participants received an equivalent amount of individual treatment and less group therapy than those receiving OCC, but demonstrated large, sustained treatment effects over a broad range of outcomes and achieved significantly greater improvement in core BPD symptoms, depression, parasuicide, and recreational drug use over the 30-month study. These results suggest that DDP is a cost-effective treatment that can lead to broad and sustained improvement for the dually diagnosed subgroup.

Entities:  

Mesh:

Year:  2010        PMID: 20386259     DOI: 10.1097/NMD.0b013e3181d6172d

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  10 in total

1.  The effectiveness of psychodynamic psychotherapies: An update.

Authors:  Peter Fonagy
Journal:  World Psychiatry       Date:  2015-06       Impact factor: 49.548

2.  Counseling on Access to Lethal Means (CALM): An Evaluation of a Suicide Prevention Means Restriction Training Program for Mental Health Providers.

Authors:  Elizabeth Sale; Michelle Hendricks; Virginia Weil; Collin Miller; Scott Perkins; Suzanne McCudden
Journal:  Community Ment Health J       Date:  2017-11-28

Review 3.  Borderline personality disorder and comorbid addiction: epidemiology and treatment.

Authors:  Thorsten Kienast; Jutta Stoffers; Felix Bermpohl; Klaus Lieb
Journal:  Dtsch Arztebl Int       Date:  2014-04-18       Impact factor: 5.594

Review 4.  Treatment for comorbid borderline personality disorder and alcohol use disorders: a review of the evidence and future recommendations.

Authors:  Mayumi O Gianoli; J Serrita Jane; Erin O'Brien; Elizabeth Ralevski
Journal:  Exp Clin Psychopharmacol       Date:  2012-06-11       Impact factor: 3.157

Review 5.  Psychological therapies for people with borderline personality disorder.

Authors:  Jutta M Stoffers; Birgit A Völlm; Gerta Rücker; Antje Timmer; Nick Huband; Klaus Lieb
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

6.  Deficits in emotion-regulation skills predict alcohol use during and after cognitive-behavioral therapy for alcohol dependence.

Authors:  Matthias Berking; Matthias Margraf; David Ebert; Peggilee Wupperman; Stefan G Hofmann; Klaus Junghanns
Journal:  J Consult Clin Psychol       Date:  2011-06

7.  Randomized trial of dual-focused vs. single-focused individual therapy for personality disorders and substance dependence.

Authors:  Samuel A Ball; Lisa M Maccarelli; Donna M LaPaglia; Mark J Ostrowski
Journal:  J Nerv Ment Dis       Date:  2011-05       Impact factor: 2.254

8.  Psychological therapies for people with borderline personality disorder.

Authors:  Ole Jakob Storebø; Jutta M Stoffers-Winterling; Birgit A Völlm; Mickey T Kongerslev; Jessica T Mattivi; Mie S Jørgensen; Erlend Faltinsen; Adnan Todorovac; Christian P Sales; Henriette E Callesen; Klaus Lieb; Erik Simonsen
Journal:  Cochrane Database Syst Rev       Date:  2020-05-04

Review 9.  Current state of the evidence on community treatments for people with complex emotional needs: a scoping review.

Authors:  Sarah Ledden; Luke Sheridan Rains; Merle Schlief; Phoebe Barnett; Brian Chi Fung Ching; Brendan Hallam; Mia Maria Günak; Thomas Steare; Jennie Parker; Sarah Labovitch; Sian Oram; Steve Pilling; Sonia Johnson
Journal:  BMC Psychiatry       Date:  2022-09-05       Impact factor: 4.144

10.  Addiction and will.

Authors:  Brian Johnson
Journal:  Front Hum Neurosci       Date:  2013-09-11       Impact factor: 3.169

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.